Neutralizing IL-12 during Induction of Murine Acute Graft-Versus-Host Disease Polarizes the Cytokine Profile Toward a Th2-Type Alloimmune Response and Confers Long Term Protection from Disease

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1208-1215

  Williamson, Eilidh ^a   Garside, Paul ^a   Bradley, J Andrew ^a,b   More, Ian A R ^a   Mowat, Allan McI ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIBODY; CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 12;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CHIMERA; CROSS BREEDING; DBA MOUSE; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; IMMUNOPHENOTYPING; KIDNEY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MORTALITY; MOUSE; PATHOLOGY; SURVIVAL; TH2 CELL;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES; CHIMERA; CROSSES, GENETIC; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; INTERLEUKIN-12; ISOANTIGENS; KIDNEY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SURVIVAL ANALYSIS; TH2 CELLS;

EID: 0031202296     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gleichmann, E., S. T. Pals, A. G. Rolink, T. Radaszkiewicz, and H. Gleichmann. 1984. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 5:324.
2. Gleichmann, H., E. Gleichmann, J. Andre-Schwartz, and R. S. Schwartz. 1972. Chronic allogeneic disease. III. Genetic requirements for the induction of glomerulonephritis. J. Exp. Med. 135:516.
3. Mowat, A. McI., and M. V. Felstein. 1990. Experimental studies of immunologically mediated enteropathy. V. Destructive enteropathy during an acute graft-versus-host reaction in adult BDF1 mice. Clin. Exp. Immunol. 79:279.
4. Mowat, A. McI. 1997. Intestinal graft-versus-host disease. In Grafi-vs.-Host Disease, 2nd Ed. J. L. M. Ferrara, H. J. Deeg, and S. J. Burakoff, eds. Marcel Dekker, Inc., New York, pp. 337-384.
5. van Elven, E. H., A. G. Rolink, F. van der Veen, and E. Gleichmann. 1981. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells: a non-H-2 locus determines the inability to induce lethal graft-versus-host disease. J. Exp. Med. 153:1474.
6. Via, C. S., and G. M. Shearer. 1988. T cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9:207.
7. Gleichmann, E., E. H. van Elven, and J. P. W. van der Veen. 1982. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12:152.
8. Allen, R. D., T. A. Staley, and C. L. Sidman. 1993. Differential cytokine expression in acute and chronic murine graft-versus-host disease. Eur. J. Immunol. 23:333.
9. Garside, P., S. Reid, M. Steel, and A. McI. Mowat. 1994. Differential cytokine production associated with distinct phases of murine graft-versus-host reaction. Immunology 82:211.
10. Via, C. S., and F. D. Finkelman. 1993. Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int. Immunol. 5:565.
11. De Wit, D., M. Van Mechelen, C. Zanin, J.-M. Doutrelepont, T. Velu, C. Gerard, D. Abramowicz, J.-P. Scheerlinck, P. De Baetselier, J. Urbain, O. Leo, M. Goldman, and M. Moser. 1993. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150:361.
12. Romagnani, S. 1992. Induction of Th1 and Th2 responses: a key role for the "natural" immune response? Immunol. Today 13:379.
13. + T cells. Annu. Rev. Immunol. 12:635.
14. Trinchieri, G., and P. Scott. 1994. The role of interleukin 12 in the immune response, disease and therapy. Immunol. Today 15:460.
15. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
16. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
17. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533.
18. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol. 153:5167.
19. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cylokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
20. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
21. Manetti, R., P. Parronchi, M. G. Giudizi, M.-P. Piccini, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (Interleukin 12) induces T helper type 1 (Th1) -specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp. Med. 177:1199.
22. Williamson, E., P. Garside, J. A. Bradley, and A. M. Mowat. 1996. Interleukin 12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157:689.
23. Garside, P., M. Steel, E. A. Worthey, A. Satoskar, J Alexander, H. Bluethmann, F. Y. Liew, and A. M. Mowat. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154:5649.
24. Luzuy, S., J. Merino, H. Engers, S. Izui, and P. H. Lambert. 1986. Autoimmunity after induction of neonatal tolerance to alloamigens: role of B cell chimerism and F1 donor B cell activation. J. Immunol. 136:4420.
25. Pals, S. T., H. Gleichmann, and E. Gleichmann. 1984. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GvHD contain F1 reactive allohelper but no allosuppressor T cells. J Exp. Med. 159:508.
26. Relink, A. G., T. Radaszkiewicz, S. T. Pals, W. G. J. Van der Meer, and E. Gleichmann. 1982. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs-host disease. J. Exp. Med. 155:1501.
27. + T cells. J. Immunol. 155:2396.
28. Rolink, A. G., and E. Gleichmann. 1983. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host (GvH) disease. III. Different lyt subsets of donor T cells induce different pathological syndromes. J. Exp. Med. 158:546.
29. Pals, S. T., T. Radaszkiewicz, and E. Gleichmann. 1984. Allosuppressor- and allohelper-T cells in acute and chronic graft-versus-host disease. IV. Activation of donor allosuppressor cells is confined to acute GvHD. J. Immunol. 132:1669.
30. Mowat, A. McI. 1989. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 68:18.
31. Cleveland, M. G., C. R. Annable, and G. R. Kumpel. 1988. In vivo and in vitro production of IFN-β and IFN-γ during graft vs host disease. J. Immunol. 141: 3349.
32. Kumpel, G. R., C. R. Annable, M. G. Cleveland, T. R. Jerrells, and J. C. Patterson. 1990. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-γ production. J. Immunol. 144: 84.
33. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
34. Picotti, J. R., S. Y. Chan, R. E. Goodman, J. Magram, E. J. Eichwald, and D. K. Bishop. 1996. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection: evidence against a dominant protective role for T helper 2 cytokines in alloimmunily. J. Immunol. 157:1951.
35. Via, C. S., S. O. Sharrow, and G. M. Shearer. 1987. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-versus-host disease. J. Immunol. 139:1840.
36. van Elven, E. H., F. M. van der Veen, A. G. Rolink, P. Issa, T. M. Duin, and E. Gleichmann. 1981. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. V. High titers of IgG autoantibodies to double-stranded DNA. J. Immunol. 127:2435.
37. Rolink, A. G., H. Gleichmann, and E. Gleichmann. 1983. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis. J. Immunol. 130:209.